Archives
Julian Eyre | published on 30th July 2018
Initial Margin – OTC derivatives and collateral management
Simon Davies – With the next phase of Initial Margin counterparts due to go live in September 2018, and two further phases in 2019 and 2020, there is expected to be an explosion in the number of firms processing and using collateral to meet OTC derivatives’ insatiable appetite.
What lessons can the industry learn from the implementations so far, and how will the demand and increase processing requirements affect firms already processing IM and those due to start?
Talk to us at the Field Effect to find out more. Please click here for more information
